Pandemic Responder Service Award Act

Health Insurance Coverage (general); Health Disparities (general); Breastfeeding (general); Assisted Reproductive Technology (general); Smoking Cessation (general); Substance Use Disorder (general); Gynecologic Cancer (general); Gynecologic Devices (general); Reproductive Health (general); Intimate Partner Violence (general); Gun Violence (general); Immunization (general); Breast Cancer (general); Medical Liability Reform (general); Health IT (general); Patient-Physician Relationship (general); Child Welfare (general); Prematurity (general); Maternal Mortality and Morbidity (general); Graduate Medical Education (general); Contraception (general); Abortion (general); Indian Health (general); Teaching Health Centers Graduate Medical Education (general); Community Health Centers (general); National Health Service Corps (general); Special Diabetes Program (general); Special Diabetes Program for Indians (general); Sexuality Education (general); Teen Pregnancy Prevention Program (general); Personal Responsibility Education Program (general); Research in Pregnant and Breastfeeding Women (general); Health Care Reform (general); Title X Family Planning Program (general); Womens Preventive Services (general); Administrative Burden (general); Surprise Billing (general); Pediatric Loan Repayment Program (general); COVID-19 Response (general); Personal Protective Equipment (general); Risk Evaluation and Mitigation Strategies (general); Data Collection (general); Health Equity (general); Pregnancy Risk Assessment Monitoring System (CDC); Provider Relief Fund (general); Maternal Mental Health (general); Violence Against Women Act (general); Secretarys Advisory Committee on Infant Mortality (general); COVID-19 Vaccine (general); H.R. 2975/S. 1645, Womens Health Protection Act; S. 1895, Lower Health Care Costs Act; H.R. 2862/S. 1619, VACCINES Act; implementation of P.L. 115-344, Preventing Maternal Deaths Act; implementation of P.L. 115-320, Improving Access to Maternity Care Act; S. 2586, Maternal Outcomes Matter Act; HR 3630, No Surprises Act; HR 3502, Protecting People From Surprise Medical Bills Act; H.R. 4495, Maternal Health Quality Improvement Act of 2019; H.R. 5640/S. 3152, the Data Mapping to Save Moms Lives Act; H.R. 6142/ S. 3424, the Black Maternal Health Momnibus Act of 2020 implementation of P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020; implementation of P.L. 116-127, the Families First Coronavirus Response Act; implementation of P.L. 116-136, the Coronavirus Aid, Relief, and Economic Security Act; implementation of P.L. 116-139, Paycheck Protection Program and Health Care Enhancement Act; H.R. 7059 the Coronavirus Provider Protection Act; H.R. 6953/ S. 3763 the Pandemic Responder Service Award Act; H.R. 6697, the Local Chamber, Tourism, and 501(c)(6) Protection Act; S.___, the Health, Economic Assistance, Liability Protection, and Schools Act; H.R. 2694, the Pregnant Workers Fairness Act; H.R. 8027, the Maternal Health Pandemic Response Act; HRes 1069/ SRes 655, Declaring racism a public health crisis; S. 4269 the Mothers and Newborns Success Act; S. 4349, Lorna Breen Health Care Provider Protection Act; H.R. 6701/S. 3595, Ensuring Understanding of COVID-19 to Protect Public Health Act; H.R. 8061/S. 4737, Community Immunity During COVID-19 Act; H.R. 8958/ S.4949, Supporting Best Practices for Healthy Moms Act; S.4863, HEALTH for MOM Act of 2020; H.R. 6383, Uterine Fibroid Research and Education Act; S.4859, Connected MOM Act.

Client expense: $147,955 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Indian Health Service, Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Small Business Administration (SBA), State, Dept of (DOS), Substance Abuse & Mental Health Services Administration (SAMHSA), U.S. Agency for International Development (USAID), Veterans Affairs, Dept of (VA), White House Office

Healthcare and COVID-19 measures included in the Consolidated Appropriations Act of 2020 (H.R. 133) Public Health and Social Services Emergency Fund (coronavirus relief packages-H.R. 6201, H.R. 748, H.R. 7010, H.R. 6800, H.R. 6800, HEALS Act, S. 4775, H.R. 133) Provider Relief Fund Reporting Requirements Regulatory relief in light of coronavirus (all coronavirus relief packages - H.R. 6074, H.R. 6201, H.R. 748, H.R. 7010, H.R. 6800, H.R. 6800, HEALS Act, S. 4775, H.R. 133) Healthcare Workforce Resilience Act (S. 3599/H.R. 6788) Hospital Price Transparency (surprise medical bills; public posting of hospital charges; Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First; Final Rule on Price Transparency; Transparency in Coverage Proposed Rule; inpatient prospective payment system rule) Surprise Medical Bills (H.R. 133; H.R. 5826; H.R. 3630; S. 1531) Liability relief (S. 4317; all coronavirus relief packages - H.R. 6074, H.R. 6201, H.R. 748, H.R. 7010, H.R. 6800; H.R. 6800, HEALS Act, S. 4775, H.R. 133) H.R. 7538, Essential Workforce Parity Act (providing liability relief and amending FMLA leave provisions) S. 3763 / H.R. 6953, Pandemic Responder Service Award Act Hospital preparedness program (H.R. 6074) 340B Drug Pricing Program (S. 4160) Public Health Emergency designation Vaccine distribution Maternal Mortality (S. 4949, Supporting Best Practices for Healthy Moms Act)

Client expense: $100,000 · Firm income: Not reported

COBRA support S.4653, A bill to protect the healthcare of hundreds of millions of people of the United States and prevent efforts of the Department of Justice to advocate courts to strike down the Patient Protection and Affordable Care Act, Entirety Monitor the following: Executive actions on An America-First Healthcare Plan Executive Order on Lowering Drug Prices by Putting America First Executive Order on Improving Rural Health and Telehealth Access Executive Order on Lowering Prices for Patients by Eliminating Kickbacks to Middlemen Executive Order on Increasing Drug Importation to Lower Prices for American Patients Executive Order on Access to Affordable Life-saving Medications Healthcare extenders: continued delay of cuts to payments supporting disproportionate share hospitals and an extension of funding for Community Health Centers H.R.3, Lower Drug Costs Now Act, Entirety H.R. 1309/S.851, Workplace Violence Prevention for Health Care and Social Service Workers Act, Entirety Affordability of pharmaceuticals, generally Treating gun violence as a public health epidemic related issues S.1357, Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act, Entirety Surprise medical billing, generally Nurse Overtime and Patient Safety Act, Entirety H.R.5800, The Ban Surprise Billing Act, Entirety H.R.5826, Consumer Protections Against Surprise Medical Bills Act, Entirety S.696 the National Nurse Act, Entirety H.R. 1425, the Patient Protection and Affordable Care Enhancement Act, Entirety Health Equity Issues during COVID Pandemic S.3763, Pandemic Responder Service Award Act, Entirety H.R.7288, Taxpayer Research and Coronavirus Knowledge Act, Entirety H.R.7296, Make Medications Affordable by Preventing Pandemic Pricegouging Act, Entirety H.R.7113, COVID-19 Emergency Manufacturing Act, Entirety S.3799, HEAL for Immigrant Women and Families Act, Entirety National Infrastructure for Mitigating the Impact of COVID-19 within Racial and Ethnic Minority Communities grant program Support Medicare/ACA enrollment H.R. 6637, Health Equity and Accountability Act, Entirety Nondiscrimination in Health and Health Education Programs and Activities, Final Rule (RIN 0945-AA11) Delivery of healthcare services to students during COVID pandemic Telehealth issues S.3599 Healthcare Workforce Resilience Act Political interference in work of experts H.R.6514, Worker Health Coverage Protection Act Emergency PPE Petition Department of Health and Human Services Regulations/Programs, Proposed Rule: Securing Updated and Necessary Statutory Evaluations Timely (Sunset Proposal)

FY 2021 Financial Services and General Government Appropriations--Lobbied against implementation of pro-contractor revision of OMB Circular A-76, contracting out, and contractor compensation. FY 2021 Financial Services and General Government Appropriations--Lobbied for protection of blue collar pay, white collar pay, minimum wage, federal retirement systems, and union representation. FY 2021 Financial Services and General Government Appropriations--Lobbied for full funding for the Office of Personnel Management (OPM) and to prohibit any funds from being spent to merge OPM with the General Services Administration (GSA) or Office of Management and Budget (OMB). FY 2021 Financial Services and General Government Appropriations--Lobbied in support of protecting federal employee collective bargaining rights. FY 2021 Financial Services and General Government Appropriations--Lobbied in support of a 3.5% pay increase for federal workers. FY 2021 Financial Services and General Government Appropriations--Lobbied for parity with military pay increase. Lobbied in support of a technical fix to the paid parental leave provision in the FY 2020 NDAA that would ensure all federal employees have access to federal paid parental leave. Lobbied in support of H.R. 5399/S. 3015, the "Locality Pay Equity Act" to limit the number of local wage areas allowable within a General Schedule pay locality. Lobbied in support of S. 944, the "Strengthening American Transportation Security Act," which would grant Transportation Security Officers (TSOs) rights under Title 5 of the U.S. code and for inclusion of H.R. 1140, the Rights for TSA Officers Act in H.R. 2 and lobbied for passage of H.R. 2, the INVEST Act. Lobbied in support of H.R. 372, the "Honoring Our Fallen TSA Officers Act," granting public safety officer benefits to TSOs killed or injured in the line of duty. Lobbied in support of H.R. 1174/S. 1942, the "Federal Firefighters Fairness Act of 2019," to amend chapter 81 of title 5, creating a presumption that a disability or death of a federal employee in fire protection activities caused by any of certain diseases is the result of the performance of such employee's duty. Lobbied in support of H.R. 1255, the "Federal Firefighter Pay Equity Act," to provide for more accurate computation of retirement benefits for federal firefighters. Lobbied in support of S. 858, the "Protecting Military Firefighters from PFAS Act," requiring the Secretary of Defense to provide blood testing for firefighters in the Department of Defense to determine potential exposure to perfluoroalkyl and polyfluoroalkyl substances. Lobbied in support of H.R. 1195/S. 473, the "Law Enforcement Officer Equity Act," to include certain federal positions within the definition of law enforcement officer for retirement purposes. Lobbied for H.R. 748, the "Middle Class Health Benefits Tax Repeal Act of 2019," to the excise tax on employer-sponsored health care coverage for which there is an excess benefit (high-cost plans). Lobbied for H.R. 860, Social Security 2100 Act, to increase various Old Age, Survivors, and Disability Insurance (OASDI) benefits and related taxes. Lobbied to support S. 478 and H.R. 1170, Social Security Expansion Act, to enhance Social Security benefits and ensure the long-term solvency of the Social Security program. Lobbied on effects on workforce of proposed Sustainability Awareness Act. Lobbied on appointees to the Merit Systems Protection Board and Federal Labor Relations Authority. Lobbied in support of S. 2525, guaranteeing the "Equipment Safety for Firefighters Act." Lobbied in support of H.R. 582, the "Raise the Wage Act." Lobbied in support of H.R. 2474, the "Protecting the Right to Organize Act of 2019." Lobbied against H.R. 4090, the "Do Your Job Act of 2019." Lobbied in support of H.R. 3607, the "Fossil Energy Research and Development Act." Lobbied in support of H.R. 1534/S. 1174, the "Federal Employee Paid Leave Act" that would grant federal workers 12 weeks of paid FMLA. Lobbied in support of H.R. 6906 the Pandemic Heroes Compensation Act to provide compensation for injuries to any individual, or their families, who are deemed an essential worker and required to leave their home to perform services and who have become ill or died as a result of COVID-19. Lobbied in support of H.R. 6139 the COVID-19 Health Care Worker Protection Act of 2020 that would direct the Secretary of Labor to issue an emergency temporary standard that requires certain employers to develop and implement a comprehensive infectious disease exposure control plan to protect employees in the health care sectors and other employees at elevated risk from exposure to SARS- CoV-2. Lobbied in support of H.R. 6955 the Essential Worker Pandemic Compensation Act of 2020 that would amend the Public Health Service Act to authorize a program of death and hospitalization benefits for essential workers who die as a result of COVID-19 or related complications. Lobbied in support of S. 4347, the Federal Labor-Management COVID Partnership Act. Lobbied in support of a presumption of worksite illness for employees who apply for workers comp who get COVID-19. Lobbied in support of H.R. 6246, the "Protecting Collective Bargaining and Official Time for Federal Workers Act." Lobbied in support of H.R. 6909, the Pandemic Heroes Compensation Act. Lobbied in support of S. 3677/H.R. 6559, the "COVID-19 Every Worker Protection Act." Lobbied in support of introduction of the Fair and Accurate Information Reporting (FAIR) Act to assist consumers with their credit reports during pandemic job loss. Lobbied in support of H.R. 6733, the "Federal Frontline Worker Leave Protection Act." Lobbied in support of S. 3561, the "Emergency Telework Act of 2020." Lobbied in support of H.R. 2694, the Pregnant Workers Fairness Act. Lobbied in support of H.R. 8457/S. 4777, the Federal Worker Leave Fairness Act to restore leave lost by Federal employees during certain public health emergencies, and for other purposes. Lobbied in support of H.R. 7340, the Chai Suthammanont Remembrance Act to ensure that personal protective equipment and other equipment and supplies needed to fight coronavirus are provided to employees required to return to Federal offices, and for other purposes. Lobbied in support of H.R. 7496, the COVID PREPARE Act to require Federal agencies to submit plans for responding to any resurgence of COVID-19. Lobbied in support of H.R. 7524/S. 4610, the Wear Your Mask Act to require face masks in Federal facilities to prevent the transmission of SARS-CoV-2. Lobbied in support of S. 4347, the Federal Labor-Management COVID Partnership Act to establish a Coronavirus Rapid Response Federal Labor-Management Task Force, and for other purposes. Lobbied in support of H.R. 7076/S. 3855, the Coronavirus Oversight and Recovery Ethics (CORE) Act to ensure ethical and accountable use of COVID-19 relief funds, to prevent corruption and bias in the disbursement and supervision of those funds. Lobbied in support of H.R. 6373 to increase the amount available under the "Defense Production Act of 1950" to respond to the coronavirus epidemic. Lobbied in support of S. 3570 to provide for the expedited procurement of equipment needed to combat COVID-19 under the "Defense Production Act of 1950." Lobbied in support of H.R. 6398 the Frontline Health Care Workers Assistance Act to direct certain actions to procure equipment necessary to prevent, identify, and mitigate cases of COVID-19 (i.e., coronavirus disease 2019). Lobbied in support of S. 3763 the Pandemic Responder Service Award Act to provide a flexible award for front line health care workers who have responded to the COVID-19 pandemic that can be used to pay off existing student loans, to obtain further education or to establish a savings account to help workers purchase housing, save for retirement or establish a childrens savings account for their dependents. Lobbied in support of H.R. 6390/S. 3568, the Medical Supply Chain Emergency Act of 2020 directing the President to use existing authorities under the Defense Production Act of 1950 with respect to the production of ventilators, N-95 respirator masks, and specified personal protective equipment to address COVID-19. Lobbied in support of H.R. 6410 directing the President to use authority under the "Defense Production Act of 1950" to ensure an adequate supply of equipment necessary for limiting the spread of COVID-19. Lobbied in support of H.R. 6746, the Emergency Benefits for Independent Workers Program Act to require the Secretary of Labor to establish a program for providing portable benefits to eligible workers. Lobbied in support of H.R. 6442/S. 3513, the Providing Americans Insured Days of Leave Act of 2020 to provide Americans with paid sick time and paid leave so that they can address their own health needs and the health needs of their families. Lobbied in support of H.R. 933 a congressional resolution recognizing COVID-19 frontline workers. Lobbied in support of H.R. 8349 to provide hazard pay to frontline essential workers employed during the COVID-19 pandemic. Lobbied in opposition to forced suspension of withholding FICA taxes from federal employees payroll Sept.-Dec. 2020 to be repaid Jan.-Apr. 2021 and for waiving or extending the repayment plan. Lobbied for legislation to make the payroll tax deferral optional for federal employees. Provided statement for the record to the Senate Homeland Security and Governmental Affairs on its hearing, Modernizing Federal Telework: Moving Forward Using the Lessons Learned During the COVID-19 Pandemic. Lobbied against forced retirement or termination of federal employees who have been injured on the job and have had their medical treatment delayed because of COVID-19. Lobbied for lawmakers to support efforts to restart collective bargaining with Department of Education employees and provide adequate funding and oversight of the Departments mission, including protecting students civil rights and fairly and equitably provide student loans. Lobbied for emergency funding for the aviation industry to protect jobs of airline and airport workers. Lobbied for H.R. 9052, a bill to nullify the Presidents Executive Order creating Schedule F by imposing limits on excepting competitive service positions from the competitive service. Lobbied for H.R. 8687, Saving the Civil Service Act, a bill to nullify the Presidents Executive Order creating Schedule F. Lobbied for H.R. 8629 and S. 4810, Protecting Employees from Surprise Taxes Act of 2020, a bill to prohibit employers from deferring payment of payroll taxes unless affected employees provide written consent to a deferral. Lobbied against confirmation of John Gibbs to be director of the Office of Personnel Management (OPM). FY 2020 Emergency Supplemental Coronavirus Pandemic Response Appropriations - Lobbied for passage of and inclusion of federal workforce provisions in H.R. 925, the Heroes Act; H.R. 8015, the Delivering for America Act; and H.R. 8319, the FY 2020 Continuing Appropriations and Other Extensions Act. FY 2020 Supplemental Appropriations - Lobbied for passage of and inclusion of federal workforce provisions in H.R. 8900 making continuing appropriations for FY 2020 through December 18, 2020. Lobbied for passage of H.J.Res. 107, making continuing appropriations for FY 2020 through December 20, 2020; lobbied for passage of H.J.Res. 110, making continuing appropriations for FY 2020 through December 21, 2020; lobbied for passage of H.R. 1520, making continuing appropriations for FY 2020 through December 28, 2020. FY 2021 Omnibus Appropriations, H.R. 133 - Lobbied for passage of and inclusion of emergency coronavirus pandemic response provisions for FY 2021, including hazard pay, presumption of workplace illness for frontline employees who contract Covid-19, an OSHA emergency standard and additional PPE and resources to distribute the vaccine to federal workers.

H.R. 4674, College Affordability Act S. 2557, Student Aid Improvement Act S. 4257, Student Loan Repayment and FAFSA Simplification Act S. 4322, Safely Back to School and Back to Work Act Issues: Support affordable income driven repayment plans for borrowers. Oppose cuts to graduate/professional student loan and repayment plans, including Public Service Loan Forgiveness (PSLF) and elimination of GradPLUS loans. H.R. 6720, Student Loan Forgiveness for Frontline Health Workers Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act S.3763, Pandemic Responder Service Award Act H.R. 6395, William M. (Mac) Thornberry National Defense Authorization Act of 2021 Issue: Support loan forgiveness for health care professionals. Issue: Support a change to the Department of Education Financial Aid Handbook redefining academic year for medical student loan disbursements. Issue: Support single accreditation system for graduate medical education Issue: Educate Congress and the administration on the impact of medical education debt on career decisions like specialty choice. H.R.103, Foreign Medical School Accountability Fairness Act of 2019 Issue: Support transparency for all international medical schools. H.R. 3418, Protecting Our Students by Terminating Graduate Rates that Add to Debt Act Issue: Support the reinstatement of federal direct Stafford loans to graduate and professional students Issue: Urge Department of Education to delay Sec. 117 and Title IX regulatory changes due to COVID-19 Issue: Support the consideration of race in holistic admissions. Oppose policies that prevent recognition of systemic racism on campus and curtail reforms to advance diversity.

Client expense: $1,095,000 · Firm income: Not reported

The Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074) Families First Coronavirus Response Act (H.R. 6201) The Coronavirus Aid, Relief, and Economic Security Act (H.R. 748, S. 3548) Paycheck Protection Program Flexibility Act of 2020 (H.R. 7010) Health and Economic Recovery Omnibus Emergency Solutions Act (H.R. 6800) HEALS Act; S. 4775, Delivering Immediate Relief to America's Families, Schools and Small Businesses Act Public Health and Social Services Emergency Fund (coronavirus relief packages-H.R. 6201, H.R. 748, H.R. 7010, H.R. 6800, H.R. 6800, HEALS Act, S. 4775) Provider Relief Fund Reporting Requirements Regulatory relief in light of coronavirus (all coronavirus relief packages - H.R. 6074, H.R. 6201, H.R. 748, H.R. 7010, H.R. 6800, H.R. 6800, HEALS Act, S. 4775) Healthcare Workforce Resilience Act (S. 3599/H.R. 6788) Hospital Price Transparency (surprise medical bills; public posting of hospital charges; Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First; Final Rule on Price Transparency; Transparency in Coverage Proposed Rule; inpatient prospective payment system rule) Surprise Medical Bills Liability relief (S. 4317; all coronavirus relief packages - H.R. 6074, H.R. 6201, H.R. 748, H.R. 7010, H.R. 6800; H.R. 6800, HEALS Act, S. 4775) H.R. 7538, Essential Workforce Parity Act (providing liability relief and amending FMLA leave provisions) S. 3763 / H.R. 6953, Pandemic Responder Service Award Act Hospital preparedness program (H.R. 6074) 340B Drug Pricing Program (S. 4160) Drug pricing policy and drug shortages Public Health Emergency designation Vaccine distribution planning

Client expense: $70,000 · Firm income: Not reported

Support HR 1763/ S 348, Resident Physician Shortage Reduction Act of 2019, a bill to amend title XVIII of the Social Security Act to provide for the distribution of additional residency positions; Oppose HR 506,Hospital Competition Act of 2019, a bill to amend title XVIII of the Social Security Act to increase hospital competition; Statement submitted to the House Judiciary on the hearing "Diagnosing the Problem: Exploring the Effects of Consolidation and Anticompetitive Conduct in Health Care Markets";Letter of support for the Senate Workgroups efforts to ensure consumer protections by addressing surprise medical bills and comments on the development of legislation to protect patients from surprise medical bills; Letter urging Congress and the Administration to take further action to help reduce input and administrative costs, as well as maximize the number of insured patients; Support HR 965/ S340, Creating and Restoring Equal Access to Equivalent Samples Act of 2019 or the CREATES Act of 2019, a bill to promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products; Support HR 986/ S466 Protecting Americans with Preexisting Conditions Act of 2019, a bill provide that certain guidance related to waivers for State innovation under the Patient Protection and Affordable Care Act shall have no force or effect; Support HR 987 Strengthening Health Care and Lowering Prescription Drug Costs Act, a bill to amend the Patient Protection and Affordable Care Act to provide for Federal Exchange outreach and educational activities; Support HR 938 Bringing Low-cost Options and Competition while Keeping Incentives for New Generics Act of 2019 or the BLOCKING Act of 2019, a bill to amend the Federal Food, Drug, and Cosmetic Act, with respect to eligibility for approval of a subsequent generic drug, to remove the barrier to that approval posed by the 180-day exclusivity period afforded to a first generic applicant that has not yet received final approval, and for other purposes; Support HR 1010, a bill to provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect; Support HR 1499 Protecting Consumer Access to Generic Drugs Act of 2019, a bill to prohibit brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products, and for other purposes; Support HR 1425 State Health Care Premium Reduction Act, a bill to amend the Patient Protection and Affordable Care Act to provide for a Improve Health Insurance Affordability Fund to provide for certain reinsurance payments to lower premiums in the individual health insurance market; Support HR 1386/ S 1905 Expand Navigators Resources for Outreach, Learning, and Longevity Act of 2019 or the ENROLL Act of 2019,a bill to amend the Patient Protection and Affordable Care Act to provide for additional requirements with respect to the navigator program, and for other purposes; Support HR 1520 Purple Book Continuity Act of 2019, a bill to amend the Public Health Service Act to provide for the publication of a list of licensed biological products, and for other purposes; Support HR 1503 Orange Book Transparency Act of 2019A bill that would increase transparency for the patent status of both approved biological products and approved drugs; Support HR 2439/ HR 3414 Opioid Workforce Act of 2019, a bill to amend title XVIII of the Social Security Act to provide for the distribution of additional residency positions to help combat the opioid crisis; Submitted statement to the House Committee on Ways and Means Overcoming Racial Disparities and Social Determinants in the Maternal Mortality Crisis sharing information regarding hospitals and health systems efforts to address maternal morbidity and mortality, as we seek ways to improve outcomes and reduce health inequities for expectant and new mothers, and give their children the best possible start in life; Submitted oral and written testimony to the House Committee on Ways and Means Subcommittee on Health Hearing on Protecting Patients from Surprise Medical Bills. Protecting patients from surprise medical bills is a top priority and we have adopted a set of guiding principles to use as we evaluate legislative proposals: Define surprise bills, Protect the patient financially, Ensure patient access to emergency care, Preserve the role of private negotiation, Remove the patient from health plan/provider negotiations, Educate patients about their health care coverage, Ensure patients have access to comprehensive provider networks and accurate network information, and Support state laws that work; Letters submitted to the Energy & Commerce Committee in response to the request for comments on their surprise billing discussion draft. Concerned with the Committees draft legislations approach to determining reimbursement for out-of-network providers. Once the patient is protected from surprise bills, providers and insurers should then be permitted to negotiate payment rates for services provided. We strongly oppose approaches that would impose arbitrary rates on providers. We look forward to continuing to work with the Committee on solutions to stop surprise medical bills; Letter sent to the HELP Committee in response to the Lower Health Care Costs Act of 2019 discussion draft about our concerns about several of the proposals that would allow the government to intrude into private commercial contracts between providers and insurers. For example, several of the provisions could undermine value-based purchasing arrangements aimed directly at improving the quality of care while reducing costs. We strongly urge the Committee to remove these provisions; Submitted oral and written testimony to the House Committee on Energy and Commerce, Subcommittee on Health Hearing on No More Surprises: Protecting Patients from Surprise Medical Bills asking that the Committee preserve the ability of providers and insurers to negotiate private contracts and not establish a fixed payment amount for out-of-network services; Oppose HR 1309 Workplace Violence Prevention for Health Care and Social Service Workers Act, a bill to direct the Secretary of Labor to issue an occupational safety and health standard that requires covered employers within the health care and social service industries to develop and implement a comprehensive workplace violence prevention plan, and for other purposes; Concerns about S.1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 or the STOP Surprise Medical Bills Act of 2019, to amend the Public Health Service Act to provide protections for health insurance consumers from surprise billing; Concerns about S. 1895 Lower Health Care Costs Act Letter addressed concerns about the legislative provision that sets a benchmark rate in statute for the out-of-network payments, as well as provisions that seek to change privately negotiated contracting arrangements between hospitals and insurance companies; Support HR 3425, Advancing Medical Resident Training in Community Hospitals Act of 2019, to amend title XVIII of the Social Security Act to establish rules for payment for graduate medical education (GME) costs for hospitals that establish a new medical residency training program after hosting resident rotators for short durations; Expressed concerns regarding the provisions that reduce reimbursements to providers and hospitals that administer drugs the Prescription Drug Pricing Reduction Act (PDPRA) of 2019: including about Section 107, Medicare Part B Rebate by Manufacturers for Drugs or Biologicals with Prices Increasing Faster than Inflation, Section 110, Establishment of Maximum Add-on Payment for Drugs, Biologicals, and Biosimilars, this provision would establish $1,000 as the maximum add-on amount that a provider can be paid for a separately payable drug, biological or biosimilar, Section 111, Treatment of Drug Administration Services Furnished by an Off-Campus Outpatient Department of a Provider, the site neutral payment reduction would cut aggregate hospital payments; Support S. 2091, Backlog Elimination, Legal Immigration, and Employment Visa Enhancement Act, this legislation would increase the total number of employment-based visas from 140,000 to 270,000 and ensure that critical health care workers needed in the U.S. have access to employment-based visas by carving out health care workers in designated shortage occupations from the limit; Support S 350, The Competitive Health Insurance Reform Act of 2019, a bill to restore the application of the Federal antitrust laws to the business of health insurance to protect competition and consumers; Submitted statement to Subcommittee on Health of the Committee on Energy and Commerce for the hearing on Improving Maternal Health: Legislation to Advance Prevention Efforts and Access to Care; Concerns with S. 386 and HR 1044, Fairness for High-Skilled Immigrants Act of 2019, this bill increases the per-country cap on family-based immigrant visas from 7% of the total number of such visas available that year to 15%, and eliminates the 7% cap for employment-based immigrant visas. It also removes an offset that reduced the number of visas for individuals from China; Support H.R. 4538, Closing Loopholes for Orphan Drugs Act, a bill to amend title III of the Public Health Service Act to limit the orphan drug exclusion under the drug discount program under section 340B of such title; Discussions of provisions we support and those we recommend be changes in a draft bill called the Mitigating Existing Drug Shortages (MEDS) Act; Discussions in support of the allowing states to designate hospitals as necessary providers for purposes of waiving the critical access hospital mileage requirements; Provided comments to W&M on legislation to expand Health Profession Opportunity Grants; Support S. 2723, The Mitigating Emergency Drug Shortages (MEDS) Act, a bill to amend Sec. 506C of the Federal Food, Drug, and Cosmetic Act which strengthens requirements for drug manufacturers to disclose the root causes and expected duration of shortages, extends reporting requirements to active pharmaceutical ingredients manufacturers, requires manufacturers have contingency plans to ensure ongoing supply, develops recommendations to incentivize manufacturers to enter the market for drugs in shortage and examines the national security risks of shortages; Discuss DEA reductions in annual quotas for opioid products used by hospitals for sedation and pain management; Meeting with the Office of the Assistant Secretary of Preparedness and Response (ASPR) to discuss developments in the hospital preparedness program, the pilot projects for the Regional Disaster Healthcare System and other issues; Rural access to health care, including identifying core services needed in rural communities, outlining approaches and considerations for delivering those services, and examining access and quality in the rural context; ONCs proposed rule to implement the 21st Century Cures provision on information blocking; Supported members serving on the HHS Quality Summit panel, which was convened by the Deputy Secretary to gather input regarding how to improve and energize quality and safety improvement activities across health care system; Discussion with HHS on drug pricing, 340b, and price transparency policies, as well as the International Pricing Index ANPRM; Discussion with HHS about the work of Aligning for Health to address social determinants of health; Support S 2902, Strengthening Our Rural Health Workforce Act of 2019, a bill to enhance the rural health workforce; Meetings and correspondence with staff members of Senate Financing Committee on a proposal to support rural health care access (REH, re-opening necessary provider CAH, infrastructure funding); Letter to Ways & Means committee Rural and Underserved Communities Health Task Force in response to RFI on factors that contribute to health outcomes in these areas, examples of successful models and lessons from the field that address access and outcomes, and considerations for the unique circumstances of rural and underserved communities; Letter to Energy and Commerce Members regarding health information technology priorities; Letter of Support to Senate Appropriations on funding for the Centers for Disease Control and Prevention and the National Institutes of Health to study gun violence; Support S.2741 and H.R. 4932,Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019, a bill to amend title XVIII of the Social Security Act to expand access to telehealth services, and for other purposes; Support S 2603, Resolving Extended Limbo for Immigrant Employees and Families (RELIEF) Act, a bill to amend the Immigration and Nationality Act to end the immigrant visa backlog, and for other purposes; Support HR 4995, Maternal Health Quality Improvement Act of 2019, a bill to amend the Public Health Service Act to improve obstetric care and maternal health outcomes, and for other purposes; Concerns with HR 5800,Ban Surprise Billing Act, a bill to address surprise medical bills that relies on a median in-network rate to resolve out-of-network payments and allows for an independent dispute resolution process to determine the final payment. Concerned with the Committee's legislative approach to determining reimbursement for out-of-network providers. Oppose approaches that would impose arbitrary rates on providers, which could have significant consequences far beyond the scope of surprise medical bills. It is the insurers' responsibility to maintain comprehensive provider networks, and a default payment rate would remove incentives for health plans to contract with providers or to offer fair terms; Support HR 5826, Consumer Protections Against Surprise Medical Bills Act, a bill that prohibits providers from balance billing patients for emergency services or medical care the patient reasonably could have expected to be in-network, and from charging patients more than the in-network cost-sharing amount. Rather than rely on a benchmark payment rate to determine out-of-network reimbursement, the legislation provides a period for health plans and providers to negotiate out-of-network reimbursement, followed by a mediated dispute resolution process if necessary; Letter urging HHS to take regulatory actions to help hospitals and health systems prepare and respond to COVID-19; Letter requesting $100 billion to prepare and respond to COVID-19; Letter urging the Department of Labor to accurately define health care provider when promulgating regulations implementing key sections of the Families First Coronavirus Response Act; Letter sent to the President asking for the use of the Defense Production Act to increase the production of medical supplies and equipment; Letter to HHS regarding $100 billion emergency fund, asking HHS and CMS to directly and expediently distribute to rural and urban hospitals and health systems funds from the Public Health and Social Services Emergency Fund that were designated for providers in the Coronavirus Aid, Relief, and Economic Security (CARES) Act. The CARES Act increased funding by $100 billion in order to reimburse eligible health care providers for health care-related expenses or lost revenues that are attributable to COVID-19. In the letter, we urged HHS and CMS to immediately distribute funding to all hospital types in the US - with additional funding going to COVID-19 hotspots; Letter urging Congress to modernize the Stafford Act as part of its next COVID-19 legislative package to allow all hospitals to recoup financial losses from this pandemic and future disasters; Letter to the Federal Reserve System, the Federal Deposit Insurance Corporation and the Office of the Comptroller of the Currency requesting they, as primary federal regulators for insured depository institutions, take prompt action to assist health care providers on the front line of the COVID-19 pandemic should the need to do so arise; Letter to the Secretary of the Treasury and the Federal Reserve Chair of the Board of Governors urging a supplement to the New Main Street Loan Facility term sheet with prompt guidance to ensure that access to this critically-necessary loan facility will be attainable for hospitals without delay; Letter was sent to the SBA urging it to ensure that small- and mid-size public hospitals, including those that have both nonprofit and public designations, are allowed to apply for and receive loans under the newly-authorized SBA Paycheck Protection Program; Letter in response to FEMAs request for input on establishing a voluntary agreement, under the Defense Production Act, of key private sector stakeholders relevant to responding to COVID-19, urging that such an agreement account for the full breadth of COVID-19 medical supply and equipment needs; Support H.R. 6474/S.3838 Healthcare Broadband Expansion During COVID-19 Act, a bill that would provide an additional $2 billion in funding for the FCC Rural Health Care program and increase the subsidy for health care providers from 65 to 85 percent. This legislation also simplifies the program to allow for more efficient application processes and disbursement of much needed funding; Support HR 6654 Emergency COVID-19 Telehealth Response Act, a bill that would codify an expanded list of providers to deliver and bill for telehealth services during the PHE; Support HR 7233Knowing the Efficiency and Efficacy of Permanent (KEEP) Telehealth Options Act of 2020, a bill that would require the Department of Health and Human Services and the Government Accountability Office (GAO) to conduct studies to provide information about the expanded use of telehealth during the COVID-19 pandemic; Letter to Senate HELP Committee in response to request for feedback on preparing for next pandemic; Discussion about telehealth waivers and flexibilities with HHS; Discussion about CARES provider relief fund distributions with HHS; Oppose HR 6559/ S 3677 COVID-19 Every Worker Protection Act of 2020, a bill to require the Occupational Safety and Health Administration to promulgate an emergency temporary standard to protect employees from occupational exposure to SARS-CoV-2, and for other purposes; Joint letter with ANA urging Congress to act quickly to get needed resources into the health care system, so that hospitals, nurses and physicians responding to COVID-19 are able to continue to provide treatments, front-line health care personnel are able to provide care and patients are able access health care services; Statement to Committee on Ways and Means for the hearing on The Disproportionate Impact of COVID-19 on Communities of Color urging Congress to employ the resources of the National Institute on Minority Health and Health Disparities - which is congressionally-mandated to coordinate the research of the other National Institutes of Healths centers and institutes related to minority health - to research and develop approaches to specifically address the COVID-19 needs of minority populations; Advocate with Congress for full forgiveness of COVID-19 related accelerated payments received by hospitals; Support S 3781Pharmaceutical Accountability, Responsibility, and Transparency (PART) Act, a bill to increase reporting of, help mitigate potential shortages related to, and promote, accountability and transparency for pharmaceuticals and medical devices; Support S 3780 Help Onshore Manufacturing Efficiencies (HOME) for Drugs and Devices Act, a bill to encourage domestic advanced manufacturing of critical drugs and devices in order to address economic, health, and security concerns, combat shortages of critical drugs and devices, and promote increased domestic diversification of, and independence from foreign reliance on, pharmaceutical and medical device supply chains; Support S.3763 Pandemic Responder Service Award Act, a bill to establish the Pandemic Responder Service Award program to express our gratitude to front-line health care workers; Support HR 6788/ S 3599 Healthcare Workforce Resilience Act, a bill to enhance our Nations nurse and physician workforce during the COVID-19 crisis by recapturing unused immigrant visas; Urged support for joint House and Senate letter to the Administration asking for flexibility for hospitals with respect to J-1 and H-1B visa programs; Letter to Senate Finance Committee to address the important issue of maternal health and the opportunity to provide suggestions regarding how to improve maternal health in this country; Support the Temporary Reciprocity to Ensure Access to Treatment Act, a bill that allows for the temporary reciprocity for treatment by medical professionals licensed in one state to patients in other states; Letter urging the Senate to include in the next COVID-19 relief bill provisions to strengthen the federal response for racial and ethnic minority and marginalized communities, which are disproportionately affected by the pandemic;Letter asking Congress to allocate as part of the next COVID-19 relief package at least an additional $100 billion to the emergency relief fund to provide direct funding to front line health care personnel and providers to continue to respond to this pandemic; Letter sent to HHS urging them to direct HRSA to take action to stop three drug manufacturers from limiting the distribution of 340B drugs to 340B covered entities. These drug manufacturers have taken separate actions to either limit the distribution of 340B drugs or require 340B covered entities provide claims level data for investigatory purposes if that 340B covered entity uses a contract pharmacy arrangement; Letter to the Congressional Leadership asking them to not to include in the next COVID-19 relief package any surprise medical billing legislation - such as a reimbursement rate set in statute - that would further destabilize hospitals finances during the pandemic; Support S 4507, Getting Early Treatment and Comprehensive Assessments Reduces Emergencies Act of 2020 or the GET CARE Act of 2020, a bill to amend the Public Health Service Act to provide for a national campaign to raise awareness of the importance of seeking preventive health services and the utilization of such services; Comment letter addressing concerns on the proposed rule from the Departments of the Treasury, Labor and Health and Human Services that would allow certain grandfathered health plans to increase patient cost-sharing beyond current limits, without losing their grandfathered status; Letter urging the Administration to work with the AHA and Congress to create a future for telehealth that allows not only clinicians, but also hospitals and health systems, to code and bill for virtual services. We further urge CMS and HHS to continue to provide hospitals with the flexibility for annual beneficiary consent to telehealth treatment to be obtained at the same time, and not necessarily before, services are furnished; Support HR 8061,Community Immunity During COVID-19 Act of 2020, a bill that would provide funding to state and local health departments to work with community providers and organizations to increase immunization rates for Advisory Committee on Immunization Practices (ACIP)-recommended vaccines during the COVID-19 public health emergency; Letter again expressing concern with recent actions taken by several major drug manufacturers to limit the distribution of certain 340B drugs to our hospital members. While we understand that the HRSA is further investigating these actions, we urge swift and decisive action to halt these pernicious tactics so as to prevent other manufacturers from following suit; Comment letter outlining our concerns about the ability of hospital systems to distribute provider relief funds among the parent and subsidiaries. HHS published certain FAQs that place problematic restrictions on the use of CARES Act provider relief fund dollars. Specifically, the FAQs restrict the ability of a hospital system to allocate the funds throughout its system where COVID-19 related expenses and lost revenues are occurring; Submitted comments in response to HRSAs RFI on Health Professional Shortage Area (HPSA) scoring. HPSA scores are important for rural hospitals and clinics ability to recruit physicians and other clinicians, namely from the National Health Service Corps (NHSC) program. Letter asking HHS to reinstate the COVID-19 Provider Relief Fund reporting requirements.

FY 2021 Financial Services and General Government Appropriations--Lobbied against implementation of pro-contractor revision of OMB Circular A-76, contracting out, and contractor compensation. FY 2021 Financial Services and General Government Appropriations--Lobbied for protection of blue collar pay, white collar pay, minimum wage, federal retirement systems, and union representation. FY 2021 Financial Services and General Government Appropriations--Lobbied for full funding for the Office of Personnel Management (OPM) and to prohibit any funds from being spent to merge OPM with the General Services Administration (GSA) or Office of Management and Budget (OMB). FY 2021 Financial Services and General Government Appropriations--Lobbied in support of protecting federal employee collective bargaining rights. FY 2021 Financial Services and General Government Appropriations--Lobbied in support of a 3.5% pay increase for federal workers. Lobbied in support of H.R. 5690/S. 3231, the "FAIR Act" in support of a 3.5% pay increase for federal workers. Lobbied in support of a technical fix to the paid parental leave provision in the FY 2020 NDAA that would ensure all federal employees have access to federal paid parental leave. Lobbied in support of H.R. 5399/S. 3015, the "Locality Pay Equity Act" to limit the number of local wage areas allowable within a General Schedule pay locality. Lobbied in support of S. 944, the "Strengthening American Transportation Security Act," which would grant Transportation Security Officers (TSOs) rights under Title 5 of the U.S. code and for inclusion of H.R. 1140, the Rights for TSA Officers Act in H.R. 2 and lobbied for passage of H.R. 2, the INVEST Act. Lobbied in support of H.R. 372, the "Honoring Our Fallen TSA Officers Act," granting public safety officer benefits to TSOs killed or injured in the line of duty. Lobbied in support of H.R. 1174/S. 1942, the "Federal Firefighters Fairness Act of 2019," to amend chapter 81 of title 5, creating a presumption that a disability or death of a federal employee in fire protection activities caused by any of certain diseases is the result of the performance of such employee's duty. Lobbied in support of H.R. 1255, the "Federal Firefighter Pay Equity Act," to provide for more accurate computation of retirement benefits for federal firefighters. Lobbied in support of S. 858, the "Protecting Military Firefighters from PFAS Act," requiring the Secretary of Defense to provide blood testing for firefighters in the Department of Defense to determine potential exposure to perfluoroalkyl and polyfluoroalkyl substances. Lobbied in support of H.R. 1195/S. 473, the "Law Enforcement Officer Equity Act," to include certain federal positions within the definition of law enforcement officer for retirement purposes. Lobbied for H.R. 748, the "Middle Class Health Benefits Tax Repeal Act of 2019," to the excise tax on employer-sponsored health care coverage for which there is an excess benefit (high-cost plans). Lobbied for H.R. 860, Social Security 2100 Act, to increase various Old Age, Survivors, and Disability Insurance (OASDI) benefits and related taxes. Lobbied to support S. 478 and H.R. 1170, Social Security Expansion Act, to enhance Social Security benefits and ensure the long-term solvency of the Social Security program. Lobbied on effects on workforce of proposed Sustainability Awareness Act. Lobbied on appointees to the Merit Systems Protection Board and Federal Labor Relations Authority. Lobbied in support of S. 2525, guaranteeing the "Equipment Safety for Firefighters Act." Lobbied in support of H.R. 582, the "Raise the Wage Act." Lobbied in support of H.R. 2474, the "Protecting the Right to Organize Act of 2019." Lobbied against H.R. 4090, the "Do Your Job Act of 2019." Lobbied in support of H.R. 3607, the "Fossil Energy Research and Development Act." Lobbied in support of H.R. 1534/S. 1174, the "Federal Employee Paid Leave Act" that would grant federal workers 12 weeks of paid FMLA. Lobbied in support of H.R. 6906 the Pandemic Heroes Compensation Act to provide compensation for injuries to any individual, or their families, who are deemed an essential worker and required to leave their home to perform services and who have become ill or died as a result of COVID-19. Lobbied in support of H.R. 6139 the COVID-19 Health Care Worker Protection Act of 2020 that would direct the Secretary of Labor to issue an emergency temporary standard that requires certain employers to develop and implement a comprehensive infectious disease exposure control plan to protect employees in the health care sectors and other employees at elevated risk from exposure to SARS- CoV-2. Lobbied in support of H.R. 6955 the Essential Worker Pandemic Compensation Act of 2020 that would amend the Public Health Service Act to authorize a program of death and hospitalization benefits for essential workers who die as a result of COVID-19 or related complications. Lobbied in support of development of a labor management taskforce to address COVID-19. Lobbied in support of a presumption of worksite illness for employees who apply for workers comp who get COVID-19. Lobbied in support of H.R. 6246, the "Protecting Collective Bargaining and Official Time for Federal Workers Act." Lobbied in support of H.R. 6909, the Pandemic Heroes Compensation Act. Lobbied in support of S. 3677/H.R. 6559, the "COVID-19 Every Worker Protection Act." Lobbied in support of introduction of the Fair and Accurate Information Reporting (FAIR) Act to assist consumers with their credit reports during pandemic job loss. Lobbied in support of H.R. 6733, the "Federal Frontline Worker Leave Protection Act." Lobbied in support of S. 3561, the "Emergency Telework Act of 2020." Lobbied in support of H.R. 2694, the Pregnant Workers Fairness Act. Lobbied in support of H.R. 8457/S. 4777, the Federal Worker Leave Fairness Act to restore leave lost by Federal employees during certain public health emergencies, and for other purposes. Lobbied in support of H.R. 7340, the Chai Suthammanont Remembrance Act to ensure that personal protective equipment and other equipment and supplies needed to fight coronavirus are provided to employees required to return to Federal offices, and for other purposes. Lobbied in support of H.R. 7496, the COVID PREPARE Act to require Federal agencies to submit plans for responding to any resurgence of COVID-19. Lobbied in support of H.R. 7524/S. 4610, the Wear Your Mask Act to require face masks in Federal facilities to prevent the transmission of SARS-CoV-2. Lobbied in support of S. 4347, the Federal Labor-Management COVID Partnership Act to establish a Coronavirus Rapid Response Federal Labor-Management Task Force, and for other purposes. Lobbied in support of H.R. 7076/S. 3855, the Coronavirus Oversight and Recovery Ethics (CORE) Act to ensure ethical and accountable use of COVID-19 relief funds, to prevent corruption and bias in the disbursement and supervision of those funds. Lobbied in support of H.R. 6373 to increase the amount available under the "Defense Production Act of 1950" to respond to the coronavirus epidemic. Lobbied in support of S. 3570 to provide for the expedited procurement of equipment needed to combat COVID-19 under the "Defense Production Act of 1950." Lobbied in support of H.R. 6398 the Frontline Health Care Workers Assistance Act to direct certain actions to procure equipment necessary to prevent, identify, and mitigate cases of COVID-19 (i.e., coronavirus disease 2019). Lobbied in support of S. 3763 the Pandemic Responder Service Award Act to provide a flexible award for front line health care workers who have responded to the COVID-19 pandemic that can be used to pay off existing student loans, to obtain further education or to establish a savings account to help workers purchase housing, save for retirement or establish a childrens savings account for their dependents. Lobbied in support of H.R. 6390/S. 3568, the Medical Supply Chain Emergency Act of 2020 directing the President to use existing authorities under the Defense Production Act of 1950 with respect to the production of ventilators, N-95 respirator masks, and specified personal protective equipment to address COVID-19. Lobbied in support of H.R. 6410 directing the President to use authority under the "Defense Production Act of 1950" to ensure an adequate supply of equipment necessary for limiting the spread of COVID-19. Lobbied in support of H.R. 6746, the Emergency Benefits for Independent Workers Program Act to require the Secretary of Labor to establish a program for providing portable benefits to eligible workers. Lobbied in support of H.R. 6442/S. 3513, the Providing Americans Insured Days of Leave Act of 2020 to provide Americans with paid sick time and paid leave so that they can address their own health needs and the health needs of their families. Lobbied in support of H.R. 933 a congressional resolution recognizing COVID-19 frontline workers. Lobbied in support of H.R. 8349 to provide hazard pay to frontline essential workers employed during the COVID-19 pandemic. FY 2020 Emergency Supplemental Coronavirus Pandemic Response Appropriations - Lobbied for passage of and inclusion of federal workforce provisions in H.R. 925, the Heroes Act; H.R. 8015, the Delivering for America Act; and H.R. 8319 ,the FY2020 Continuing Appropriations and Other Extensions Act. FY 2020 Supplemental Appropriations - Lobbied for passage of H.R. 8337 making continuing appropriations for FY 2020 the December 12, 2020 [for Homeland only - including the Emergency Stopgap USCIS Stabilization Act]. Lobbied in support of S. 4136 the "COST of Relocations Act." Lobbied in support of making the payroll tax deferral optional for federal employees. Lobbied in support of S. 4518, the "Pandemic Federal Telework Act of 2020." Lobbied in opposition to forced suspension of withholding FICA taxes from federal employees payroll Sept. - Dec. 2020 to be repaid Jan. - Apr. 2021 and in support of passage of H.R. 8171, the "Save Our Social Security Now Act." Lobbied against forced retirement or termination of federal employees who have been injured on the job and have had their medical treatment delayed because of COVID-19. Lobbied for lawmakers to support efforts to restart collective bargaining with Department of Education employees and provide adequate funding and oversight of the Departments mission, including protecting students civil rights and fairly and equitably provide student loans. Lobbied for emergency funding for the aviation industry to protect jobs of airline and airport workers. Lobbied in support of continuation of the A-76 public-private competition moratorium. FY 2020 Emergency Supplemental Coronavirus Pandemic Response Appropriations - Lobbied for passage of and inclusion of federal workforce provisions in H.R. 925, the Heroes Act; H.R. 8015, the Delivering for America Act; and H.R. 8319 , the FY 2020 Continuing Appropriations and Other Extensions Act. FY 2020 Supplemental Appropriations - Lobbied for passage of H.R. 8337 making continuing appropriations for FY 2020 through December 11, 2020.

S.3599 Healthcare Workforce Resilience Act Political interference in work of experts H.R.6514, Worker Health Coverage Protection Act Emergency PPE Petition, AFT H.R.1603, Alan Reinstein Ban Asbestos Now Act of 2019, Entirety S.4653, A bill to protect the healthcare of hundreds of millions of people of the United States and prevent efforts of the Department of Justice to advocate courts to strike down the Patient Protection and Affordable Care Act, Entirety Monitor the following: Executive actions on An America-First Healthcare Plan Executive Order on Lowering Drug Prices by Putting America First Executive Order on Improving Rural Health and Telehealth Access Executive Order on Lowering Prices for Patients by Eliminating Kickbacks to Middlemen Executive Order on Increasing Drug Importation to Lower Prices for American Patients Executive Order on Access to Affordable Life-saving Medications Healthcare extenders: continued delay of cuts to payments supporting disproportionate share hospitals and an extension of funding for Community Health Centers H.R.3, Lower Drug Costs Now Act, Entirety H.R. 1309/S.851, Workplace Violence Prevention for Health Care and Social Service Workers Act, Entirety Affordability of pharmaceuticals, generally Treating gun violence as a public health epidemic related issues S.1357, Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act, Entirety Surprise medical billing, generally Nurse Overtime and Patient Safety Act, Entirety H.R.5800, The Ban Surprise Billing Act, Entirety H.R.5826, Consumer Protections Against Surprise Medical Bills Act, Entirety S.696 the National Nurse Act, Entirety H.R. 1425, the Patient Protection and Affordable Care Enhancement Act, Entirety Health Equity Issues during COVID Pandemic S.3763, Pandemic Responder Service Award Act, Entirety H.R.7288, Taxpayer Research and Coronavirus Knowledge Act, Entirety H.R.7296, Make Medications Affordable by Preventing Pandemic Pricegouging Act, Entirety H.R.7113, COVID-19 Emergency Manufacturing Act, Entirety S.3799, HEAL for Immigrant Women and Families Act, Entirety National Infrastructure for Mitigating the Impact of COVID-19 within Racial and Ethnic Minority Communities grant program Support Medicare/ACA enrollment H.R. 6637, Health Equity and Accountability Act, Entirety Nondiscrimination in Health and Health Education Programs and Activities, Final Rule (RIN 0945-AA11) FDA/FTC Workshop on a Competitive Marketplace for Biosimilars Docket No. FDA-2019-N-6050, FDA Delivery of healthcare services to students during COVID pandemic Telehealth issues

Health Insurance Coverage (general); Health Disparities (general); Breastfeeding (general); Assisted Reproductive Technology (general); Smoking Cessation (general); Substance Use Disorder (general); Gynecologic Cancer (general); Gynecologic Devices (general); Reproductive Health (general); Intimate Partner Violence (general); Gun Violence (general); Immunization (general); Breast Cancer (general); Medical Liability Reform (general); Health IT (general); Patient-Physician Relationship (general); Child Welfare (general); Prematurity (general); Maternal Mortality and Morbidity (general); Graduate Medical Education (general); Contraception (general); Abortion (general); Indian Health (general); Teaching Health Centers Graduate Medical Education (general); Community Health Centers (general); National Health Service Corps (general); Special Diabetes Program (general); Special Diabetes Program for Indians (general); Sexuality Education (general); Teen Pregnancy Prevention Program (general); Personal Responsibility Education Program (general); Research in Pregnant and Breastfeeding Women (general); Health Care Reform (general); Title X Family Planning Program (general); Womens Preventive Services (general); Administrative Burden (general); Surprise Billing (general); Pediatric Loan Repayment Program (general); COVID-19 Response (general); Personal Protective Equipment (general); Risk Evaluation and Mitigation Strategies (general); Data Collection (general); Health Equity (general); Pregnancy Risk Assessment Monitoring System (CDC); Provider Relief Fund (general); Maternal Mental Health (general); Violence Against Women Act (general); Secretarys Advisory Committee on Infant Mortality (general); H.R. 2975/S. 1645, Womens Health Protection Act; S. 1895, Lower Health Care Costs Act; H.R. 2862/S. 1619, VACCINES Act; implementation of P.L. 115-344, Preventing Maternal Deaths Act; implementation of P.L. 115-320, Improving Access to Maternity Care Act; S. 2586, Maternal Outcomes Matter Act; HR 3630, No Surprises Act; HR 3502, Protecting People From Surprise Medical Bills Act; H.R. 4495, Maternal Health Quality Improvement Act of 2019; H.R. 5640/S. 3152, the Data Mapping to Save Moms Lives Act; H.R. 6142/ S. 3424, the Black Maternal Health Momnibus Act of 2020 implementation of P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020; implementation of P.L. 116-127, the Families First Coronavirus Response Act; implementation of P.L. 116-136, the Coronavirus Aid, Relief, and Economic Security Act; implementation of P.L. 116-139, Paycheck Protection Program and Health Care Enhancement Act; H.R. 6800, the Heroes Act; H.R. 1425, the Affordable Care Act Enhancement Act; H.R. 7059 the Coronavirus Provider Protection Act; H.R. 6953/ S. 3763 the Pandemic Responder Service Award Act; H.R. 6697, the Local Chamber, Tourism, and 501(c)(6) Protection Act; S.___, the Health, Economic Assistance, Liability Protection, and Schools Act; H.R. 2694, the Pregnant Workers Fairness Act; H.R. 8027, the Maternal Health Pandemic Response Act; S. 4524, the Quit Because of COVID-19 Act; HRes 1069/ SRes 655, Declaring racism a public health crisis; S. 4269 the Mothers and Newborns Success Act; S. 4349, Lorna Breen Health Care Provider Protection Act.

The Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074) Families First Coronavirus Response Act (H.R. 6201) The Coronavirus Aid, Relief, and Economic Security Act (H.R. 748, S. 3548) Paycheck Protection Program Flexibility Act of 2020 (H.R. 7010) Health and Economic Recovery Omnibus Emergency Solutions Act (H.R. 6800) Public Health and Social Services Emergency Fund (coronavirus relief packages-H.R. 6201, H.R. 748, H.R. 7010, H.R. 6800) Regulatory relief in light of coronavirus ((all coronavirus relief packages - H.R. 6074, H.R. 6201, H.R. 748, H.R. 7010, H.R. 6800) Hospital Price Transparency (surprise medical bills; public posting of hospital charges; Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First; Final Rule on Price Transparency; Transparency in Coverage Proposed Rule) Surprise Medical Bills (coronavirus relief packages-H.R. 6201, H.R. 748, H.R. 7010, H.R. 6800) Liability relief (all coronavirus relief packages - H.R. 6074, H.R. 6201, H.R. 748, H.R. 7010, H.R. 6800) S. 3763 / H.R. 6953, Pandemic Responder Service Award Act Hospital preparedness program (H.R. 6074) 340B Drug Pricing Program Drug pricing policy and drug shortages

Client expense: $250,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 4674, College Affordability Act S. 2557, Student Aid Improvement Act Presidents Budget Request, FY 2021 Draft Senate Higher Education Act reauthorization Department of Education Higher Education Act reauthorization proposal Issues: Oppose cuts to graduate/professional student loan and repayment plans, including Public Service Loan Forgiveness (PSLF) and elimination of GradPLUS loans. H.R. 6720, Student Loan Forgiveness for Frontline Health Workers Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act S.3763, Pandemic Responder Service Award Act Issue: Support loan forgiveness for health care professionals. Issue: Support a change to the Department of Education Financial Aid Handbook redefining academic year for medical student loan disbursements. Issue: Support single accreditation system for graduate medical education Issue: Educate Congress and the administration on the impact of medical education debt on career decisions like specialty choice. H.R.103, Foreign Medical School Accountability Fairness Act of 2019 Issue: Support transparency for all international medical schools. H.R. 3418, Protecting Our Students by Terminating Graduate Rates that Add to Debt Act Issue: Support the reinstatement of federal direct Stafford loans to graduate and professional students Issue: Urge Department of Education to delay Sec. 117 and Title IX regulatory changes due to COVID-19

Client expense: $1,316,000 · Firm income: Not reported

Support HR 1763/ S 348, Resident Physician Shortage Reduction Act of 2019, a bill to amend title XVIII of the Social Security Act to provide for the distribution of additional residency positions; Oppose HR 506,Hospital Competition Act of 2019, a bill to amend title XVIII of the Social Security Act to increase hospital competition; Statement submitted to the House Judiciary on the hearing "Diagnosing the Problem: Exploring the Effects of Consolidation and Anticompetitive Conduct in Health Care Markets";Letter of support for the Senate Workgroups efforts to ensure consumer protections by addressing surprise medical bills and comments on the development of legislation to protect patients from surprise medical bills; Letter urging Congress and the Administration to take further action to help reduce input and administrative costs, as well as maximize the number of insured patients; Support HR 965/ S340, Creating and Restoring Equal Access to Equivalent Samples Act of 2019 or the CREATES Act of 2019, a bill to promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products; Support HR 986/ S466 Protecting Americans with Preexisting Conditions Act of 2019, a bill provide that certain guidance related to waivers for State innovation under the Patient Protection and Affordable Care Act shall have no force or effect; Support HR 987 Strengthening Health Care and Lowering Prescription Drug Costs Act, a bill to amend the Patient Protection and Affordable Care Act to provide for Federal Exchange outreach and educational activities; Support HR 938 Bringing Low-cost Options and Competition while Keeping Incentives for New Generics Act of 2019 or the BLOCKING Act of 2019, a bill to amend the Federal Food, Drug, and Cosmetic Act, with respect to eligibility for approval of a subsequent generic drug, to remove the barrier to that approval posed by the 180-day exclusivity period afforded to a first generic applicant that has not yet received final approval, and for other purposes; Support HR 1010, a bill to provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect; Support HR 1499 Protecting Consumer Access to Generic Drugs Act of 2019, a bill to prohibit brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products, and for other purposes; Support HR 1425 State Health Care Premium Reduction Act, a bill to amend the Patient Protection and Affordable Care Act to provide for a Improve Health Insurance Affordability Fund to provide for certain reinsurance payments to lower premiums in the individual health insurance market; Support HR 1386/ S 1905 Expand Navigators Resources for Outreach, Learning, and Longevity Act of 2019 or the ENROLL Act of 2019,a bill to amend the Patient Protection and Affordable Care Act to provide for additional requirements with respect to the navigator program, and for other purposes; Support HR 1520 Purple Book Continuity Act of 2019, a bill to amend the Public Health Service Act to provide for the publication of a list of licensed biological products, and for other purposes; Support HR 1503 Orange Book Transparency Act of 2019A bill that would increase transparency for the patent status of both approved biological products and approved drugs; Support HR 2439/ HR 3414 Opioid Workforce Act of 2019, a bill to amend title XVIII of the Social Security Act to provide for the distribution of additional residency positions to help combat the opioid crisis; Submitted statement to the House Committee on Ways and Means Overcoming Racial Disparities and Social Determinants in the Maternal Mortality Crisis sharing information regarding hospitals and health systems efforts to address maternal morbidity and mortality, as we seek ways to improve outcomes and reduce health inequities for expectant and new mothers, and give their children the best possible start in life; Submitted oral and written testimony to the House Committee on Ways and Means Subcommittee on Health Hearing on Protecting Patients from Surprise Medical Bills. Protecting patients from surprise medical bills is a top priority and we have adopted a set of guiding principles to use as we evaluate legislative proposals: Define surprise bills, Protect the patient financially, Ensure patient access to emergency care, Preserve the role of private negotiation, Remove the patient from health plan/provider negotiations, Educate patients about their health care coverage, Ensure patients have access to comprehensive provider networks and accurate network information, and Support state laws that work; Letters submitted to the Energy & Commerce Committee in response to the request for comments on their surprise billing discussion draft. Concerned with the Committees draft legislations approach to determining reimbursement for out-of-network providers. Once the patient is protected from surprise bills, providers and insurers should then be permitted to negotiate payment rates for services provided. We strongly oppose approaches that would impose arbitrary rates on providers. We look forward to continuing to work with the Committee on solutions to stop surprise medical bills; Letter sent to the HELP Committee in response to the Lower Health Care Costs Act of 2019 discussion draft about our concerns about several of the proposals that would allow the government to intrude into private commercial contracts between providers and insurers. For example, several of the provisions could undermine value-based purchasing arrangements aimed directly at improving the quality of care while reducing costs. We strongly urge the Committee to remove these provisions; Submitted oral and written testimony to the House Committee on Energy and Commerce, Subcommittee on Health Hearing on No More Surprises: Protecting Patients from Surprise Medical Bills asking that the Committee preserve the ability of providers and insurers to negotiate private contracts and not establish a fixed payment amount for out-of-network services; Oppose HR 1309 Workplace Violence Prevention for Health Care and Social Service Workers Act, a bill to direct the Secretary of Labor to issue an occupational safety and health standard that requires covered employers within the health care and social service industries to develop and implement a comprehensive workplace violence prevention plan, and for other purposes; Concerns about S.1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 or the STOP Surprise Medical Bills Act of 2019, to amend the Public Health Service Act to provide protections for health insurance consumers from surprise billing; Concerns about S. 1895 Lower Health Care Costs Act Letter addressed concerns about the legislative provision that sets a benchmark rate in statute for the out-of-network payments, as well as provisions that seek to change privately negotiated contracting arrangements between hospitals and insurance companies; Support HR 3425, Advancing Medical Resident Training in Community Hospitals Act of 2019, to amend title XVIII of the Social Security Act to establish rules for payment for graduate medical education (GME) costs for hospitals that establish a new medical residency training program after hosting resident rotators for short durations; Expressed concerns regarding the provisions that reduce reimbursements to providers and hospitals that administer drugs the Prescription Drug Pricing Reduction Act (PDPRA) of 2019: including about Section 107, Medicare Part B Rebate by Manufacturers for Drugs or Biologicals with Prices Increasing Faster than Inflation, Section 110, Establishment of Maximum Add-on Payment for Drugs, Biologicals, and Biosimilars, this provision would establish $1,000 as the maximum add-on amount that a provider can be paid for a separately payable drug, biological or biosimilar, Section 111, Treatment of Drug Administration Services Furnished by an Off-Campus Outpatient Department of a Provider, the site neutral payment reduction would cut aggregate hospital payments; Support S. 2091, Backlog Elimination, Legal Immigration, and Employment Visa Enhancement Act, this legislation would increase the total number of employment-based visas from 140,000 to 270,000 and ensure that critical health care workers needed in the U.S. have access to employment-based visas by carving out health care workers in designated shortage occupations from the limit; Support S 350, The Competitive Health Insurance Reform Act of 2019, a bill to restore the application of the Federal antitrust laws to the business of health insurance to protect competition and consumers; Submitted statement to Subcommittee on Health of the Committee on Energy and Commerce for the hearing on Improving Maternal Health: Legislation to Advance Prevention Efforts and Access to Care; Concerns with S. 386 and HR 1044, Fairness for High-Skilled Immigrants Act of 2019, this bill increases the per-country cap on family-based immigrant visas from 7% of the total number of such visas available that year to 15%, and eliminates the 7% cap for employment-based immigrant visas. It also removes an offset that reduced the number of visas for individuals from China; Support H.R. 4538, Closing Loopholes for Orphan Drugs Act, a bill to amend title III of the Public Health Service Act to limit the orphan drug exclusion under the drug discount program under section 340B of such title; Discussions of provisions we support and those we recommend be changes in a draft bill called the Mitigating Existing Drug Shortages (MEDS) Act; Discussions in support of the allowing states to designate hospitals as necessary providers for purposes of waiving the critical access hospital mileage requirements; Provided comments to W&M on legislation to expand Health Profession Opportunity Grants; Support S. 2723, The Mitigating Emergency Drug Shortages (MEDS) Act, a bill to amend Sec. 506C of the Federal Food, Drug, and Cosmetic Act which strengthens requirements for drug manufacturers to disclose the root causes and expected duration of shortages, extends reporting requirements to active pharmaceutical ingredients manufacturers, requires manufacturers have contingency plans to ensure ongoing supply, develops recommendations to incentivize manufacturers to enter the market for drugs in shortage and examines the national security risks of shortages; Discuss DEA reductions in annual quotas for opioid products used by hospitals for sedation and pain management; Meeting with the Office of the Assistant Secretary of Preparedness and Response (ASPR) to discuss developments in the hospital preparedness program, the pilot projects for the Regional Disaster Healthcare System and other issues; Rural access to health care, including identifying core services needed in rural communities, outlining approaches and considerations for delivering those services, and examining access and quality in the rural context; ONCs proposed rule to implement the 21st Century Cures provision on information blocking; Supported members serving on the HHS Quality Summit panel, which was convened by the Deputy Secretary to gather input regarding how to improve and energize quality and safety improvement activities across health care system; Discussion with HHS on drug pricing, 340b, and price transparency policies, as well as the International Pricing Index ANPRM; Discussion with HHS about the work of Aligning for Health to address social determinants of health; Support S 2902, Strengthening Our Rural Health Workforce Act of 2019, a bill to enhance the rural health workforce; Meetings and correspondence with staff members of Senate Financing Committee on a proposal to support rural health care access (REH, re-opening necessary provider CAH, infrastructure funding); Letter to Ways & Means committee Rural and Underserved Communities Health Task Force in response to RFI on factors that contribute to health outcomes in these areas, examples of successful models and lessons from the field that address access and outcomes, and considerations for the unique circumstances of rural and underserved communities; Letter to Energy and Commerce Members regarding health information technology priorities; Letter of Support to Senate Appropriations on funding for the Centers for Disease Control and Prevention and the National Institutes of Health to study gun violence; Support S.2741 and H.R. 4932,Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019, a bill to amend title XVIII of the Social Security Act to expand access to telehealth services, and for other purposes; Support S 2603, Resolving Extended Limbo for Immigrant Employees and Families (RELIEF) Act, a bill to amend the Immigration and Nationality Act to end the immigrant visa backlog, and for other purposes; Support HR 4995, Maternal Health Quality Improvement Act of 2019, a bill to amend the Public Health Service Act to improve obstetric care and maternal health outcomes, and for other purposes; Concerns with HR 5800,Ban Surprise Billing Act, a bill to address surprise medical bills that relies on a median in-network rate to resolve out-of-network payments and allows for an independent dispute resolution process to determine the final payment. Concerned with the Committee's legislative approach to determining reimbursement for out-of-network providers. Oppose approaches that would impose arbitrary rates on providers, which could have significant consequences far beyond the scope of surprise medical bills. It is the insurers' responsibility to maintain comprehensive provider networks, and a default payment rate would remove incentives for health plans to contract with providers or to offer fair terms; Support HR 5826, Consumer Protections Against Surprise Medical Bills Act, a bill that prohibits providers from balance billing patients for emergency services or medical care the patient reasonably could have expected to be in-network, and from charging patients more than the in-network cost-sharing amount. Rather than rely on a benchmark payment rate to determine out-of-network reimbursement, the legislation provides a period for health plans and providers to negotiate out-of-network reimbursement, followed by a mediated dispute resolution process if necessary; Letter urging HHS to take regulatory actions to help hospitals and health systems prepare and respond to COVID-19; Letter requesting $100 billion to prepare and respond to COVID-19; Letter urging the Department of Labor to accurately define health care provider when promulgating regulations implementing key sections of the Families First Coronavirus Response Act; Letter sent to the President asking for the use of the Defense Production Act to increase the production of medical supplies and equipment; Letter to HHS regarding $100 billion emergency fund, asking HHS and CMS to directly and expediently distribute to rural and urban hospitals and health systems funds from the Public Health and Social Services Emergency Fund that were designated for providers in the Coronavirus Aid, Relief, and Economic Security (CARES) Act. The CARES Act increased funding by $100 billion in order to reimburse eligible health care providers for health care-related expenses or lost revenues that are attributable to COVID-19. In the letter, we urged HHS and CMS to immediately distribute funding to all hospital types in the US - with additional funding going to COVID-19 hotspots; Letter urging Congress to modernize the Stafford Act as part of its next COVID-19 legislative package to allow all hospitals to recoup financial losses from this pandemic and future disasters; Letter to the Federal Reserve System, the Federal Deposit Insurance Corporation and the Office of the Comptroller of the Currency requesting they, as primary federal regulators for insured depository institutions, take prompt action to assist health care providers on the front line of the COVID-19 pandemic should the need to do so arise; Letter to the Secretary of the Treasury and the Federal Reserve Chair of the Board of Governors urging a supplement to the New Main Street Loan Facility term sheet with prompt guidance to ensure that access to this critically-necessary loan facility will be attainable for hospitals without delay; Letter was sent to the SBA urging it to ensure that small- and mid-size public hospitals, including those that have both nonprofit and public designations, are allowed to apply for and receive loans under the newly-authorized SBA Paycheck Protection Program; Letter in response to FEMAs request for input on establishing a voluntary agreement, under the Defense Production Act, of key private sector stakeholders relevant to responding to COVID-19, urging that such an agreement account for the full breadth of COVID-19 medical supply and equipment needs; Support H.R. 6474/S.3838 Healthcare Broadband Expansion During COVID-19 Act, a bill that would provide an additional $2 billion in funding for the FCC Rural Health Care program and increase the subsidy for health care providers from 65 to 85 percent. This legislation also simplifies the program to allow for more efficient application processes and disbursement of much needed funding; Support HR 6654 Emergency COVID-19 Telehealth Response Act, a bill that would codify an expanded list of providers to deliver and bill for telehealth services during the PHE; Support HR 7233Knowing the Efficiency and Efficacy of Permanent (KEEP) Telehealth Options Act of 2020, a bill that would require the Department of Health and Human Services and the Government Accountability Office (GAO) to conduct studies to provide information about the expanded use of telehealth during the COVID-19 pandemic; Letter to Senate HELP Committee in response to request for feedback on preparing for next pandemic; Discussion about telehealth waivers and flexibilities with HHS; Discussion about CARES provider relief fund distributions with HHS; Oppose HR 6559/ S 3677 COVID-19 Every Worker Protection Act of 2020, a bill to require the Occupational Safety and Health Administration to promulgate an emergency temporary standard to protect employees from occupational exposure to SARS-CoV-2, and for other purposes; Joint letter with ANA urging Congress to act quickly to get needed resources into the health care system, so that hospitals, nurses and physicians responding to COVID-19 are able to continue to provide treatments, front-line health care personnel are able to provide care and patients are able access health care services; Statement to Committee on Ways and Means for the hearing on The Disproportionate Impact of COVID-19 on Communities of Color urging Congress to employ the resources of the National Institute on Minority Health and Health Disparities - which is congressionally-mandated to coordinate the research of the other National Institutes of Healths centers and institutes related to minority health - to research and develop approaches to specifically address the COVID-19 needs of minority populations; Advocate with Congress for full forgiveness of COVID-19 related accelerated payments received by hospitals; Support S 3781Pharmaceutical Accountability, Responsibility, and Transparency (PART) Act, a bill to increase reporting of, help mitigate potential shortages related to, and promote, accountability and transparency for pharmaceuticals and medical devices; Support S 3780 Help Onshore Manufacturing Efficiencies (HOME) for Drugs and Devices Act, a bill to encourage domestic advanced manufacturing of critical drugs and devices in order to address economic, health, and security concerns, combat shortages of critical drugs and devices, and promote increased domestic diversification of, and independence from foreign reliance on, pharmaceutical and medical device supply chains; Support S.3763 Pandemic Responder Service Award Act, a bill to establish the Pandemic Responder Service Award program to express our gratitude to front-line health care workers; Support HR 6788/ S 3599 Healthcare Workforce Resilience Act, a bill to enhance our Nations nurse and physician workforce during the COVID-19 crisis by recapturing unused immigrant visas; Urged support for joint House and Senate letter to the Administration asking for flexibility for hospitals with respect to J-1 and H-1B visa programs; Letter to Senate Finance Committee to address the important issue of maternal health and the opportunity to provide suggestions regarding how to improve maternal health in this country; Support the Temporary Reciprocity to Ensure Access to Treatment Act, a bill that allows for the temporary reciprocity for treatment by medical professionals licensed in one state to patients in other states.

H.R. 1425, the Patient Protection and Affordable Care Enhancement Act, Entirety Health Equity Issues during COVID Pandemic S.3763, Pandemic Responder Service Award Act, Entirety H.R.7288, Taxpayer Research and Coronavirus Knowledge Act, Entirety H.R.7296, Make Medications Affordable by Preventing Pandemic Pricegouging Act, Entirety H.R.7113, COVID-19 Emergency Manufacturing Act, Entirety S.3799, HEAL for Immigrant Women and Families Act, Entirety National Infrastructure for Mitigating the Impact of COVID-19 within Racial and Ethnic Minority Communities grant program Support Medicare/ACA enrollment H.R. 6637, Health Equity and Accountability Act, Entirety Nondiscrimination in Health and Health Education Programs and Activities, Final Rule (RIN 0945-AA11) FDA/FTC Workshop on a Competitive Marketplace for Biosimilars Docket No. FDA-2019-N-6050, FDA Delivery of healthcare services to students during COVID pandemic Monitor the following: H.R.3, Lower Drug Costs Now Act, Entirety H.R. 1309/S.851, Workplace Violence Prevention for Health Care and Social Service Workers Act, Entirety Affordability of pharmaceuticals, generally Treating gun violence as a public health epidemic related issues S.1357, Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act, Entirety Surprise medical billing, generally Nurse Overtime and Patient Safety Act, Entirety H.R.5800, The Ban Surprise Billing Act, Entirety H.R.5826, Consumer Protections Against Surprise Medical Bills Act, Entirety S.696 the National Nurse Act, Entirety

Client expense: $440,000 · Firm income: Not reported

Health Insurance Coverage (general); Health Disparities (general); Breastfeeding (general); Assisted Reproductive Technology (general); Smoking Cessation (general); Substance Use Disorder (general); Gynecologic Cancer (general); Gynecologic Devices (general); Reproductive Health (general); Intimate Partner Violence (general); Gun Violence (general); Immunization (general); Breast Cancer (general); E-Cigarettes (general); Medical Liability Reform (general); Health IT (general); Patient-Physician Relationship (general); Conscience Refusals (general); Child Welfare (general); Prematurity (general); Maternal Mortality and Morbidity (general); Graduate Medical Education (general); Contraception (general); Abortion (general); Indian Health (general); Teaching Health Centers Graduate Medical Education (general); Community Health Centers (general); National Health Service Corps (general); Special Diabetes Program (general); Special Diabetes Program for Indians (general); Sexuality Education (general); Teen Pregnancy Prevention Program (general); Personal Responsibility Education Program (general); Research in Pregnant and Breastfeeding Women (general); Health Care Reform (general); Title X Family Planning Program (general); Womens Preventive Services (general); Drug Pricing (general); Administrative Burden (general); Surprise Billing (general); Pediatric Loan Repayment Program (general);COVID-19 Response (general); Personal Protective Equipment (general); Risk Evaluation and Mitigation Strategies (general); Data Collection (general); Health Equity (general); Maternal Mental Health (general);; Violence Against Women Act (general); Secretarys Advisory Committee on Infant Mortality (general); H.R. 2975/S. 1645, Womens Health Protection Act; S. 1895, Lower Health Care Costs Act; H.R. 2862/S. 1619, VACCINES Act; implementation of P.L. 115-344, Preventing Maternal Deaths Act; implementation of P.L. 115-320, Improving Access to Maternity Care Act; S. 2586, Maternal Outcomes Matter Act; HR 3630, No Surprises Act; HR 3502, Protecting People From Surprise Medical Bills Act; H.R. 4495, Maternal Health Quality Improvement Act of 2019; H.R. 5640/S. 3152, the Data Mapping to Save Moms Lives Act; H.R. 6142/ S. 3424, the Black Maternal Health Momnibus Act of 2020; H.R. 6159, Kids Access to Primary Care Act of 2020; S. 4088, Ensuring Access to Primary Care for Women & Children Act; H.R. 6383, Uterine Fibroid Research and Education Act of 2020; implementation of P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020; implementation of P.L. 116-127, the Families First Coronavirus Response Act; implementation of P.L. 116-136, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, Paycheck Protection Program and Health Care Enhancement Act; H.R. 6800, the Heroes Act; H.R. 1425, the Affordable Care Act Enhancement Act; H.R. 7059 the Coronavirus Provider Protection Act; H.R. 6953/ S. 3763 the Pandemic Responder Service Award Act; H.R. 6697, the Local Chamber, Tourism, and 501(c)(6) Protection Act; H.Res 137/ S. Res 154, Supporting the designation of the week of April 11 through April 17, 2019 as "Black Maternal Health Week".

The Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 (H.R. 6074) Families First Coronavirus Response Act (H.R. 6201) The Coronavirus Aid, Relief, and Economic Security Act (H.R. 748, S. 3548) Paycheck Protection Program Flexibility Act of 2020 (H.R. 7010) Health and Economic Recovery Omnibus Emergency Solutions Act (H.R. 6800) Public Health and Social Services Emergency Fund (coronavirus relief packages-H.R. 6201, H.R. 748, H.R. 7010, H.R. 6800) Regulatory relief in light of coronavirus ((all coronavirus relief packages - H.R. 6074, H.R. 6201, H.R. 748, H.R. 7010, H.R. 6800) Hospital Price Transparency (surprise medical bills; public posting of hospital charges; Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First; Final Rule on Price Transparency; Transparency in Coverage Proposed Rule) Surprise Medical Bills (coronavirus relief packages-H.R. 6201, H.R. 748, H.R. 7010, H.R. 6800) Liability relief (all coronavirus relief packages - H.R. 6074, H.R. 6201, H.R. 748, H.R. 7010, H.R. 6800) S. 3763 / H.R. 6953, Pandemic Responder Service Award Act Hospital preparedness program (H.R. 6074) 340B Drug Pricing Program Drug pricing policy and drug shortages

Client expense: $70,000 · Firm income: Not reported